Ask AI
ProCE Banner Activity

Guia do Paciente sobre os Últimos Avanços Clínicos em Novas Terapias para Leucemia Linfocítica Crônica ou Linfoma Linfocítico Pequeno Recorrente/Refratário

PDF

Este recurso amigável para pacientes resume os principais achados e pontos de cada estudo sobre leucemia linfocítica crônica ou linfoma linfocítico pequeno. Esses recursos condensam cada estudo em um documento de comunicação para pacientes, disponível para download, para preparar os pacientes e seus profissionais de saúde para importantes conversas de tomada de decisão compartilhada.

Released: April 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Target Audience

This activity is intended for hematologists, oncologists, and other healthcare professionals caring for patients with relapsed/refractory CLL globally.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply recently presented data to clinical practice to expand treatment options and enhance outcomes for patients with relapsed/refractory CLL

  • Appraise the potential clinical implications of new data on novel targeted and cellular therapies for treatment selection and sequencing in patients with relapsed/refractory CLL

  • Support effective shared decision-making through patient education and resources on the potential clinical implications of recently presented data for relapsed/refractory CLL

Disclosure

Primary Author

Nelson Hamerschlak, MD, PhD: consultant/advisor/speaker: BeOne, Johnson & Johnson.